NOT-GM-23-046: Termination of the Requirement for COBRE, INBRE, IDeA-CTR, and NARCH Awards to Provide Supplemental Annual Reports through the Scientific Information Reporting System (SIRS)

Termination of the Requirement for COBRE, INBRE, IDeA-CTR, and NARCH Awards to Provide Supplemental Annual Reports through the Scientific Information Reporting System (SIRS)

Notice Number:

NOT-GM-23-046

Key Dates

Release Date:

June 20, 2023

Related Announcements

June 02, 2023 - Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional). See NOFO PAR-23-166
February 10, 2023 - IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional). See NOFO PAR-23-100
December 20, 2022 - Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional). See NOFO PAR-23-063
September 14, 2022 - Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional). See NOFO PAR-22-250

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to terminate the requirement for recipients of Centers of Biomedical Research Excellence (COBRE), IDeA Networks of Biomedical Research Excellence (INBRE), IDeA Networks for Clinical and Translational Research (IDeA-CTR), and Native American Research Centers for Health (NARCH) awards to provide supplemental annual reports through the Scientific Information Reporting System (SIRS). Effective October 1, 2023, recipients of COBRE, INBRE, IDeA-CTR, and NARCH awards are required to submit annual reports through the Research Performance Progress Report (RPPR) only.

Inquiries

Please direct all inquiries to:

Ming Lei, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]